524640 ARCHITORG

Archit Organosys Share Price

 

 

Start SIP in ARCHITORG

Start SIP

Performance

  • Low
  • ₹43
  • High
  • ₹44
  • 52 Week Low
  • ₹34
  • 52 Week High
  • ₹51
  • Open Price₹43
  • Previous Close₹43
  • Volume1,111

Investment Returns

  • Over 1 Month + 3.27%
  • Over 3 Month -7.43%
  • Over 6 Month -0.67%
  • Over 1 Year -9.97%

Smart Investing Starts Here Start SIP with Archit Organosys for Steady Growth!

Invest Now

Archit Organosys Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 88
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.31
  • EPS
  • -
  • Dividend Yield
  • 1.2
  • MACD Signal
  • -0.1
  • RSI
  • 51.46
  • MFI
  • 75.12

Archit Organosys Financials

Archit Organosys Technicals

EMA & SMA

Current Price
₹43.00
+ 0.33 (0.77%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹42.21
  • 50 Day
  • ₹42.86
  • 100 Day
  • ₹43.61
  • 200 Day
  • ₹44.05

Resistance and Support

42.99 Pivot Speed
  • R3 44.78
  • R2 44.29
  • R1 43.48
  • S1 42.18
  • S2 41.69
  • S3 40.88

Archit Organosys Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results
2025-05-23 Audited Results & Dividend
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2025-09-22 FINAL Rs.0.50 per share(5%)Final Dividend
View Archit Organosys Dividend History Arrow

Archit Organosys F&O

Archit Organosys Shareholding Pattern

65.39%
30.21%
4.4%

Archit Organosys FAQs

Archit Organosys share price is ₹43 As on 01 January, 2026 | 09:52

The Market Cap of Archit Organosys is ₹88.2 Cr As on 01 January, 2026 | 09:52

The P/E ratio of Archit Organosys is 13.4 As on 01 January, 2026 | 09:52

The PB ratio of Archit Organosys is 1.2 As on 01 January, 2026 | 09:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23